We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




MDCT Used to Detect Illegal "Dissolved” Drugs

By Biotechdaily staff writers
Posted on 16 Jun 2008
The smuggling of dissolved drugs, in particular cocaine, in bottled liquids can be decreased with the use of multidetector computed tomography (MDCT) scanning, according to a recent collaborative study.

The study was conducted by researchers from the Center for Forensic Imaging, Institute of Forensic Medicine at the University of Bern, and the Federal Customs Administration (FCA), also in Bern, Switzerland. More...
The research originally consisted of MDCT scans of three wine bottles that contained cocaine solutions that were confiscated at the Swiss Border, according to Silke Grabherr, M.D., lead author of the study. Once the researchers conducted the scans of the 3 wine bottles, they did a simulated test using 12 wine bottles of which were 6 tainted with cocaine in various concentrations ranging from 10-120 g. MDCT accurately detected the bottles with the dissolved cocaine because cocaine shows an increase of the X-Ray attenuation, according to Dr. Grabherr.

According to Dr. Grabherr, fluoroscopy, traditional radiography and ultrasound have been used to detect hidden drugs, however, these techniques cannot detect dissolved drugs. "MDCT allows us to quickly detect cocaine solutions inside bottles without opening them and even without opening the cargo. If a suspicious cargo is scanned with a positive result, it can be tracked without arousing the suspicion of the smuggler. By utilizing the MDCT-screening method, the investigation does not leave any trace, therefore, smugglers won't know if their cargo was examined or not,” she said. "The fast acquisition of the data also allows screening of a large amount of cargo, for example a whole shipment, without delaying delivery of the cargo. By using the MDCT screening, the possibility that the drug [if it exists], is detected is much higher because every bottle in the cargo is examined.”

The study appears in the May 2008 issue of the American Journal of Roentgenology.


Related Links:
University of Bern
Swiss Federal Customs Administration

Platinum Member
Xylazine Immunoassay Test
Xylazine ELISA
Verification Panels for Assay Development & QC
Seroconversion Panels
POCT Fluorescent Immunoassay Analyzer
FIA Go
Gold Member
Spinal Fluid Cell Count Control
Spinalscopics
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: QIP-MS could predict and detect myeloma relapse earlier compared to currently used techniques (Photo courtesy of Adobe Stock)

Mass Spectrometry-Based Monitoring Technique to Predict and Identify Early Myeloma Relapse

Myeloma, a type of cancer that affects the bone marrow, is currently incurable, though many patients can live for over 10 years after diagnosis. However, around 1 in 5 individuals with myeloma have a high-risk... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Technology

view channel
Image: Ziyang Wang and Shengxi Huang have developed a tool that enables precise insights into viral proteins and brain disease markers (Photo courtesy of Jeff Fitlow/Rice University)

Light Signature Algorithm to Enable Faster and More Precise Medical Diagnoses

Every material or molecule interacts with light in a unique way, creating a distinct pattern, much like a fingerprint. Optical spectroscopy, which involves shining a laser on a material and observing how... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.